Through my experience, I have become educated about the inside secrets of the pharmaceutical industry. I have learned through helping clients who were victims of medical malpractice, defective drugs or medical devices, and other serious personal injuries and wrongful deaths. The sad truth is, unfortunately, we cannot place our health in the hands of large corporations, and in particular, pharmaceutical corporations.
The resource I’m offering is free, and by clicking here, you can have it immediately delivered to your inbox, and be on the road to protecting the health of yourself, your family, and your friends. It’s a quick, easy read that will empower you with vital information that you can pass on to others.
It’s been called the new “Viagra” for women. Osphena is the new sex pill for women, and Big Pharma is banking that millions will buy the drug. It is designed to treat “dysparunia”, which is moderate or severe pain during intercourse due to menopausal changes in the vagina area.
But, is this something that women really need?
According to Jennifer Block, an editor for Senior Planet, there’s more hype than help behind the drug’s claims, plus some scary risks and several unpleasant side effects.
In her article, she questions whether or not “dysparunia” is a real disorder affecting many women, or is it a simply another “backdoor” replacement for “hormone replacement therapy” with the same risks?
In case you don’t remember, the history of Hormone Replacement Therapy is quite concerning. In the 60s, the idea of menopause as a curable disease that can be treated surfaced. Sales of hormone treatments soared, and Big Pharma made lots of cash.
In 2002, the Women’s Health Initiative helped uncover the truth about this hormone replacement therapy. Not only were there no benefits whatsoever, to the contrary, there were many risks involved, and they were high. These included increased chances of breast cancer, coronary vascular disease, stroke and blood clots.
Though there is some doubt about this, and drug companies would like to see the claims thrown out, there is one statement of truth learned. Menopause is not a disease and does not necessarily need to be treated, especially if terrible risks can occur.
According to Block, dysparunia can be caused form a variety of things, like infection, or not enough foreplay. The natural changes that occur in women are kind of like hair that turns grey as we age. She believes this is all a charade, a made up disease to be treated by a drug that is completely unnecessary. Could this possibly be true?
This is the warning found on a website that informs people all about the drug, Osphena…
The warnings do not look appealing, especially if the benefits are next to nothing.
What about Viagra?
A pharmaceutical company called Pfizer developed it and it is being sold by several other large pharmaceutical, or Big Pharma companies as well. This drug for men suffering from erectile dysfunction promises to be the cure. However, it has many harsh side effects as well, and there is quite a few men who should never take it if they have Hypotension, cardiovascular risks, or a list of other problems.
It can cause severe hypotension, myocardial infarction, strokes, and even sudden death. In 2005, The FDA found that it may even cause loss of eyesight! I wonder how many users are aware of these effects.
Thank goodness the FDA is aware, but it may be too late. The FDA did not take it off the market, but ordered Big Pharma to display the effects more prominently on their products, using a black label. Pfizer faces many lawsuits claiming they did not adequately warn the public of such harmful effects.
Nobody likes to talk about sexual dysfunction, but the nasty side effects from taking these two drugs could land you in the hospital. Make sure you seek legal counsel if you are harmed and believe it may be from Osphena or Viagra. You are entitled to compensation for your injuries, and these companies need to pay their consequences for the harm they’ve caused.
Contact VanWey Law PLLC,Dallas’s Premiere Law firm, if you need an attorney who will fight for your rights.
The new popular anticoagulant Pradaxa has been linked to causing serious and even fatal bleeding events worldwide. Dallas dangerous drug attorney Kay Van Wey explains why patients should be worried about Pradaxa.
When we are given a prescription for a serious condition by our doctors, we assume that the doctor knows best and would not prescribe a dangerous medication. Unfortunately, dangerous medications are often approved with little testing by the U.S. Food and Drug Administration (FDA), and doctors can be influenced by big pharma to prescribe a certain medication, despite the lack of studies on it.
The latest controversial drug is Pradaxa, which is an anticoagulant used to treat atrial fibrillation, a condition that often affects elderly patients. Pradaxa is similar to Warfarin. Both drugs carry a similar risk of bleeding, but patients who take Pradaxa do not have to undergo the frequent blood tests required for Warfarin.
A major difference between Pradaxa and Warfarin is that unlike Warfarin, Pradaxa has no known antidote, so if a patient on Pradaxa experiences bleeding, his doctor can do little to help stop the bleeding. Recent reports suggest that elderly patients who take Pradaxa and suffer minor falls have an increased risk of experiencing a serious bleeding event.
Since its introduction on the market in 2010, Pradaxa has caused an estimated 260 deaths worldwide due to serious bleeding events. Regulators knew that Pradaxa had no known antidote when they approved the drug, and the FDA continues to allow the drug to be sold, despite incoming reports of serious bleeding events.
Emergency room doctors and surgeons are especially worried about Pradaxa’s dangerous side effects. “We have noted on multiple occasions patients who have ‘bleeding out’ from Pradaxa and our hands are tied. They’re bleeding out all over and there’s absolutely nothing we can do about it…I’m helpless and hopeless when it comes into my emergency room,” says Dr. Bryan Cotton, a trauma surgeon at Houston’s Memorial Hermann Hospital.
The FDA has not said when it will make a decision regarding the safety of Pradaxa, but diligent trial lawyers across the United States are filing lawsuits to hold Pradaxa’s manufacturer accountable for its dangerous drug. Go to www.vanweylaw.com for the latest news on Pradaxa bleeding events and upcoming Pradaxa lawsuits.
Weight loss drug Qnexa could soon be approved by the FDA, despite concerns that Qnexa causes serious birth defects because it contains dangerous drug Topamax.
Proposed weight loss drug Qnexa has not yet been approved by the U.S. Food and Drug Administration (FDA), but if approved, thousands of children could suffer Qnexa birth defects.
Qnexa Contains Dangerous Drug Topamax
Qnexa is a combination of two drugs that are known to aid in weight loss–Phentermine and Topamax. Phentermine is a stimulant that is used to suppress appetite. Topamax, generic name topiramate, is a medication approved to treat seizures and prevent migraines.
Doctors have already been prescribing Topamax to women to aid their weight loss. But many women currently taking Topamax are of child-bearing age. Studies have found that even when women take birth control pills to prevent pregnancy, Topamax reduces the effectiveness of these hormonal contraceptives, increasing the chances that a woman will get pregnant.
Many women who do become pregnant while taking Topamax do not realize that they are pregnant until months after they have been taking the drug. Additionally, Topamax can cause serious birth defects even if discontinued after the first trimester.
FDA Committee Endorses Qnexa
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted on February 28, 2012 to endorse Qnexa. Qnexa had previously been rejected by the FDA because of its potential to cause birth defects like cleft lips and cleft palates, which can severely affect a baby’s growth and development.
Topamax use during pregnancy can increase the risk that a child will have a birth defect by a factor of two to five. But experts think the FDA will still approve Qnexa despite the risk. In the past decade, the FDA has faced intense pressure from healthcare providers to approve a weight loss drug and reduce the high rate of obesity in the United States. Some experts even say the FDA should approve a potentially unsafe weight loss drug, because reversing obesity will outweigh any drug’s risk.
Millions of Women May Take Qnexa
If Qnexa is approved as a long-term weight loss drug, potentially millions of women of child-bearing age may take the drug as a way to lose weight. But Qnexa may also cause birth defects in thousands of children. Yet, big pharma will still yield profits of anywhere between $1 billion and $3 billion for this new lifestyle drug.
Qnexa has already been linked to heart palpitations, memory loss, and suicidal thoughts, along with birth defects. If approved, Qnexa could become the next dangerous drug to hit the market.
To learn more about lifestyle drugs, big pharma, and the FDA, download my free ebook Prescription Drug Safety: 7 Secrets the Pharmaceutical Industry Does NOT Want You to Know at www.vanweylaw.com.
An elderly Utah man suffered a Pradaxa serious bleeding event after sustaining minor trauma in a fall. Doctors worry that minor falls in elderly Pradaxa patients may be disastrous because Pradaxa has no antidote.
When an 83 year-old man went to University Hospital in Salt Lake City, Utah after falling at home and suffering minor trauma, his doctors never imagined he would suffer a Pradaxa serious bleeding event.
Minor Trauma Can Cause a Pradaxa Serious Bleeding Event
A case report featured in the Journal of Neurosurgery details that the 83 year-old man had been prescribed Pradaxa just a month before by his primary care physician who had diagnosed him with atrial fibrillation. Upon arriving at the hospital, the man exhibited no signs of impairment, and a brain scan showed that he had only small hemorrhages of little concern.
Within just two hours of being admitted to the hospital though, the man’s condition began to deteriorate. New brain scans showed he was suffering from extensive intracranial hemorrhaging. His doctors could do little but stand by and watch as he slipped into a coma.
The neurosurgeons who treated the man wrote this case report to alert other healthcare providers to the fact that Pradaxa has no known antidote. In fact, the doctors attempted to stop the hemorrhaging in the 83 year-old by giving him intravenous fluids and recombinant factor VIIa, which is often used to clot blood, but both treatments were ineffective.
The authors noted that because Pradaxa is broken down through the kidneys, dialysis may be the only way to reverse the effects of Pradaxa, but because bleeding events happen so suddenly, dialysis is often ineffective to stop the bleeding.
What is Pradaxa?
Pradaxa is an anticoagulant that is widely prescribed to prevent strokes and blood clots in elderly patients with atrial fibrillation. But these elderly patients are often unstable on their feet and are prone to falling, which can cause minor trauma and major hemorrhaging. Experts worry that as Pradaxa is more widely prescribed to older, frailer patients, the number of serious bleeding events will increase.
Worldwide, Pradaxa has been linked to 260 deaths as of November 2011. The U.S. Food and Drug Administration (FDA) released a safety communication for Pradaxa in December 2011, saying that it would study Pradaxa’s side effects to determine the risk of severe bleeding. In the United States, an estimated 120 deaths have been blamed on Pradaxa serious bleeding events.
While the FDA studies these adverse events, trial lawyers across the nation are standing up for consumer rights, asking manufacturer Boehringer Ingelheim for answers. Pradaxa lawsuits have been filed in U.S. district courts across the nation, alleging that Boehringer Ingelheim knew about the bleeding risks, but provided no antidote and continued to market and sell Pradaxa anyway.
To learn more about Pradaxa serious bleeding events and get the latest news on Pradaxa, visit www.vanweylaw.com. Pradaxa is not the first dangerous drug to be approved by the FDA, and it certainly will not be the last. To learn more about dangerous drug approvals, download my free ebook Prescription Drug Safety: 7 Secrets the Pharmaceutical Company Does Not Want You to Know at www.vanweylaw.com.
Paula Deen endorsed diabetes drug Victoza and is now saying it has helped her lose weight. But do the benefits of Victoza outweigh its dangerous side effects?
Video Source: khou.com
Victoza was first widely publicized and marketed when southern chef Paula Deen made the announcement that she is a diabetic.Simultaneous with her announcement, Deen endorsed Victoza, saying that the drug has helped her control her diabetes.
But what Deen didn’t know was that Victoza comes with a hefty warning that patients can develop thyroid cancer while taking the drug.
Weight Loss in a “Little Blue Pen”
Nearly two months after Deen’s not so shocking admission, she now says she has lost weight and dropped two sizes thanks to Victoza. That’s surprising, seeing as how Deen was photographed shortly after her announcement eating a very large cheeseburger while on a cruise. But part of Deen’s weight loss could also be due to the fact that she has cut her portion sizes in half and has started walking for 30 minutes a day.
While patients taking Victoza have reported experiencing a decreased appetite, the drug’s ability to cause weight loss is difficult to predict. Victoza manufacturer Novo Nordisk says that weight loss is just one of the many “beneficial” side effects of the drug. Less talked about are the dangerous side effects of Victoza, which include thyroid cancer, pancreatitis, and severe stomach problems.
Although Victoza is only approved to treat Type-2 diabetes, some critics of the drug are concerned that doctors could legally prescribe it to patients who are borderline diabetic to help them lose weight and fend off diabetes. But whether the benefits of the drug outweigh its dangerous risks remains to be seen.
Similar Dangerous Diabetes Drugs
Other diabetes drugs that are being praised for their weight loss inducing side effects include Byetta, Bydureon, and Januvia. Yet all of these drugs come with warnings of serious side effects similar to those of Victoza.
For instance, Byetta can cause pancreatitis, which is an inflammation of the pancreas that can be painful and can lead to death if not treated. Bydureon can cause a type of thyroid cancer known as medullary thyroid cancer (MTC), the symptoms of which are swelling or lumps in the neck, hoarseness, trouble swallowing, and shortness of breath. Additionally, Bydureon can cause pancreatitis, dehydration leading to kidney problems, and severe stomach problems. Januvia can cause serious side effects like pancreatitis, kidney problems, and hypoglycemia, or low blood sugar.
Big Pharma Markets Diabetes Drugs as Lifestyle Drugs
This recent development that Victoza can cause weight loss is just another tool in big pharma’s arsenal to get people to buy their drugs. Big pharma markets drugs like Victoza, Byetta, Bydureon, and Januvia as lifestyle drugs that will allow people to live their lives as they always have—eating foods high in fat and sugar and not exercising regularly. Unfortunately, there is no such thing as a “miracle diet drug” and for some patients, the benefits of taking these drugs may be outweighed by the risks the drugs pose, like thyroid cancer.
To learn more about the secrets of big pharma, download my FREE ebook Prescription Drug Safety: 7 Secrets the Pharmaceutical Industry Does NOT Want You to Know at www.vanweylaw.com.
Dallas drug injury attorney explains how a nationwide drug shortage could put people in danger if they are not able to receive medicines used to treat common injuries.
In recent weeks, news stories about cancer drugs in dangerous short supply have been capturing headlines across the nation. But few people know that cancer drugs are not the only vital drugs in short supply.
Nationwide, hospitals and ambulance companies have had to ration supplies of hundreds of medications used to treat common injuries. Some of the most commonly used drugs in short supply are:
Midazolam & Valium—used to treat seizures
Morphine & Fentanyl—used to treat pain
Zofran—used to treat nausea and vomiting
Benadryl & Epinephrine—used to treat allergic reactions
Mannitol—used to control pressure in patients who have head injuries
In the Dallas-Fort Worth area, paramedics who work for Medstar are using drugs past their expiration dates in some cases, because they simply do not have a stable supply of the medicines. While the drugs can be made by local pharmacists, they typically do not last as long as those provided by the drug companies.
Attempting to address the shortage, President Obama signed an Executive Order just last year in which he directed the FDA to prevent and reduce the number of drug shortages that have been growing over the past few years.
Pharmaceutical companies that manufacture these drugs have cut back manufacturing significantly, arguing that they make little profit on these common drugs. But the Department of Justice has launched an investigation into whether some of these pharmaceutical companies are creating artificial shortages in order to increase demand, and therefore, increase prices. If pharmaceutical companies have been illegally price-gouging or stockpiling medications, they could face criminal charges.
For now, the FDA is taking steps to protect consumers and prevent price gouging by instituting early notification requirements of potential drug shortages. Unfortunately, this may be another case of big pharma putting profits before patients and consumer safety.
To learn more about the pharmaceutical industry, download my FREE ebook Prescription Drug Safety: 7 Secrets the Pharmaceutical Industry Does NOT Want You to Know at www.vanweylaw.com.
On Victoza’s label is a warning that the drug may cause pancreatitis, much like the warnings on other diabetes drugs Byetta and Januvia. Since the drug was approved in 2010, health experts have become increasingly concerned that this drug also increases the risk of pancreatitis.
But Paula Deen is not the only celebrity who has promoted or is currently promoting a potentially dangerous drug. Other celebrities include Paul and Mira Sorvino who have promoted diabetes drug Lantus, which studies have found may double the user’s risk of getting cancer.
And diabetes drugs are not the only pharmaceutical drugs with dangerous side effects. Within the past couple of years, studies have shown that bisphosphonates, like Boniva and Fosamax, cause low impact femur fractures. Many of the patients taking these drugs who suffered femur fractures were doing simple activities at the time of the fracture, including stepping off a curb. Actress Sally Field has appeared on commercials for Boniva since 2006.
In addition, pro-golfer Phil Mickelson suffers from psoriatic arthritis, an autoimmune disease. He is currently endorsing Enbrel, a drug that blocks proteins, which can cause arthritic inflammation. Enbrel and other drugs like it suppress the immune system, putting patients at risk for contracting dangerous infections, including tuberculosis and histoplasmosis. Numerous deaths have been linked to these infections.
Finally, former Olympic champion Bruce Jenner promoted the top-selling arthritis drug Vioxx. But in 2004, Vioxx was recalled after studies found it increased the risk of heart attack. Jenner claimed that he had never been told about the risks.
Blood thinner Pradaxa has been linked to serious bleeding events in patients worldwide. As many as 260 patients on the drug have died from serious bleeding, but the FDA continues to say the drug is safe.
Since November 2011, at least 260 deaths worldwide have been linked to new blood thinner Pradaxa. An estimated 1.1 million prescriptions have already been written for Pradaxa, and 371,000 patients are currently taking the drug.
Symptoms of these adverse events include the following:
Persistent nose bleeding
Unusual gum bleeding
Vomiting or coughing up blood
Heavier than normal menstrual bleeding
Red or black stool
Pink or brown urine
Severe or uncontrollable bleeding
The FDA recommends that if you or a loved one experiences any of these symptoms, you seek the help of a health care provider immediately.
Can We Trust the FDA?
Although the FDA is currently investigating claims that Pradaxa has caused serious bleeding, the agency maintains that "[a]t this time, FDA continues to believe that Pradaxa provides an important health benefit when used as directed and recommends that healthcare professionals who prescribe Pradaxa follow the recommendations in the approved drug label.”
The FDA has made statements like this before for drugs that were later proven to indeed be very dangerous. Patients taking Avandia, for example, reported adverse events like heart attacks. The FDA had approved Avandia in 1999 simply because it helped diabetics to control blood sugar levels. But after nearly 47,000 people taking Avandia suffered a heart attack, stroke, or even death, the FDA finally restricted the use of the drug in 2010.
And it seems as though the FDA may be behind the curve on Pradaxa. Both Japan and Australia have issued safety warnings, linking Pradaxa to serous bleeding events.
To learn more about the pharmaceutical industry and why the FDA approves these dangerous drugs, download my FREE e-book Prescription Drug Safety: 7 Secrets the Pharmaceutical Industry Does NOT Want You to Know at www.vanweylaw.com today.
Paula Deen’s type-2 diabetes announcement and partnership with big pharma has drawn criticism from fans and critics alike. Pastry chef Michael Mignano began dieting and exercising after his type-2 diabetes diagnosis and has since reversed his diagnosis without using diabetes drugs.
Deen’s partnership with big pharma drew criticism not only from her critics, but also from her fans. Chef Anthony Bourdain has criticized Deen’s cooking for years, and upon learning of her announcement, took to Twitter writing “Thinking of getting into the leg-breaking business, so I can profitably sell crutches later.”
While Deen has said she has changed her eating habits and has cut out the sweet tea, many question whether she really has changed the way she eats or whether she’s simply using Victoza to counteract eating poorly. Either way, her recent partnership sends the message that people can eat what they want, and if they happen to develop diabetes, there’s a drug for that.
Mignano spent years sampling his own sugar-filled creations and picking up fast food after a long day at work. By the time he turned 36 years-old, he weighed 500 pounds and had been diagnosed with type-2 diabetes. Realizing the risks he was taking by eating unhealthy, Mignano agreed to go on “Fat Chef,” a new show on Food Network in which chefs like Mignano learn how to eat healthy and exercise.
Since filming, Mignano has lost over 100 pounds and has reversed his type-2 diabetes diagnosis, all without taking pills. “Medicine is great, but it gives you this false sense of healing, but it’s not really doing what it’s supposed to do,” he said in a recent interview with ABC News.
Mignano is the first to admit that working with the food that contributed to his obesity is not easy, and neither is getting into a regular exercise routine. But he says “It just makes me a happier chef, a happier person, which the result, you have happier food.”
Although “Fat Chef” is done filming, Mignano says he plans to stick with his diet and exercise regimen. He hopes to drop his weight down to 250 and stay diabetes free.
Big Pharma’s Influence
For years, major pharmaceutical companies have pushed diabetes drugs on Americans with ever-growing waistlines, sending the message that you can eat whatever bad food you want because a pill will nullify the food’s bad effects. But drugs like Avandia, Actos, and even Paula Deen’s Victoza may be more dangerous than helpful. Avandia was pulled from the U.S. market completely after studies showed it caused heart attacks and death. Actos is still on the market, but has been shown to cause bladder cancer. And Victoza may cause thyroid cancer and acute pancreatitis.